ATOSSA THERAPEUTICS I
1.2950
27-November-24 15:39:03
15 minutes delayed
Stocks
+0.0050
+0.39%
Today's range
1.2400 - 1.3200
ISIN
N/A
Source
NASDAQ
-
06 Mar 2024 08:30:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS Study
22 Feb 2024 08:30:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical Trial
07 Feb 2024 08:30:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Issues Letter to Shareholders
09 Jan 2024 08:30:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director
04 Dec 2023 08:30:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical Trial
20 Nov 2023 08:30:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
13 Nov 2023 09:00:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Appoints Financial Executive Jonathan Finn to its Board of Directors
09 Nov 2023 09:00:00 By Nasdaq GlobeNewswire
-
Atossa to Present at Cantor Fitzgerald Global Healthcare Conference 2023
18 Sep 2023 08:30:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
14 Aug 2023 08:30:03 By Nasdaq GlobeNewswire
-
08 Aug 2023 09:00:00 By Nasdaq GlobeNewswire
-
20 Jul 2023 09:15:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
13 Jul 2023 16:15:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Provides Enrollment Update for Ongoing Phase 2 Karisma-Endoxifen Clinical Trial
10 Jul 2023 09:15:00 By Nasdaq GlobeNewswire
-
06 Jul 2023 09:15:00 By Nasdaq GlobeNewswire
-
28 Jun 2023 09:15:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces $10M Stock Repurchase Program
27 Jun 2023 09:15:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Sponsorship of Are You Dense MusicFest 2023
22 Jun 2023 16:15:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Granted Additional Patent Protection for Endoxifen
21 Jun 2023 10:13:54 By Nasdaq GlobeNewswire
-
Atossa to Participate in Fireside Chat at Healthcare Virtual Conference Presented by Maxim Group LLC
14 Jun 2023 09:15:00 By Nasdaq GlobeNewswire